−0.153 SEK
−17.34 M SEK
1.37 M SEK
About DOUBLE BOND PHARMACEUTICAL INT. AB SER. B
Sector
Industry
CEO
Igor Lokot
Website
Headquarters
Uppsala
Founded
2014
ISIN
SE0007185525
FIGI
BBG009DFBCW8
Double Bond Pharmaceutical International AB is a pharmaceutical company, which engages in developing and commercializing approaches for treatment of cancers, infections, autoimmune diseases, and life-threatening disorders. It also involves in designing medicinal products for patients suffering from diseases such as cancer, inflammation, asthma or diabetes. The company was founded on November 21, 2014 and is headquartered in Uppsala, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DBP.B is 0.377 SEK — it has increased by 5.84% in the past 24 hours. Watch DOUBLE BOND PHARMACEUTICAL INT. AB SER. B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange DOUBLE BOND PHARMACEUTICAL INT. AB SER. B stocks are traded under the ticker DBP.B.
DBP.B stock has risen by 1.46% compared to the previous week, the month change is a 2.21% rise, over the last year DOUBLE BOND PHARMACEUTICAL INT. AB SER. B has showed a −52.88% decrease.
DBP.B reached its all-time high on Nov 6, 2018 with the price of 19.400 SEK, and its all-time low was 0.251 SEK and was reached on Aug 21, 2023. View more price dynamics on DBP.B chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DBP.B stock is 34.08% volatile and has beta coefficient of 1.06. Track DOUBLE BOND PHARMACEUTICAL INT. AB SER. B stock price on the chart and check out the list of the most volatile stocks — is DOUBLE BOND PHARMACEUTICAL INT. AB SER. B there?
Today DOUBLE BOND PHARMACEUTICAL INT. AB SER. B has the market capitalization of 44.67 M, it has decreased by −19.76% over the last week.
Yes, you can track DOUBLE BOND PHARMACEUTICAL INT. AB SER. B financials in yearly and quarterly reports right on TradingView.
DBP.B net income for the last quarter is −925.72 K SEK, while the quarter before that showed −4.87 M SEK of net income which accounts for 81.00% change. Track more DOUBLE BOND PHARMACEUTICAL INT. AB SER. B financial stats to get the full picture.
No, DBP.B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DOUBLE BOND PHARMACEUTICAL INT. AB SER. B EBITDA is −8.90 M SEK, and current EBITDA margin is −959.71%. See more stats in DOUBLE BOND PHARMACEUTICAL INT. AB SER. B financial statements.
Like other stocks, DBP.B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DOUBLE BOND PHARMACEUTICAL INT. AB SER. B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DOUBLE BOND PHARMACEUTICAL INT. AB SER. B technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DOUBLE BOND PHARMACEUTICAL INT. AB SER. B stock shows the sell signal. See more of DOUBLE BOND PHARMACEUTICAL INT. AB SER. B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.